Correlation Between GlucoTrack and Nexalin Technology

Can any of the company-specific risk be diversified away by investing in both GlucoTrack and Nexalin Technology at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlucoTrack and Nexalin Technology into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between GlucoTrack and Nexalin Technology, you can compare the effects of market volatilities on GlucoTrack and Nexalin Technology and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlucoTrack with a short position of Nexalin Technology. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlucoTrack and Nexalin Technology.

Diversification Opportunities for GlucoTrack and Nexalin Technology

-0.68

Correlation Coefficient

GlucoTrack  Nexalin Technology

Excellent diversification

The 3 months correlation between GlucoTrack and Nexalin is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding GlucoTrack and Nexalin Technology in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nexalin Technology and GlucoTrack is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlucoTrack are associated (or correlated) with Nexalin Technology. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nexalin Technology has no effect on the direction of GlucoTrack i.e., GlucoTrack and Nexalin Technology go up and down completely randomly.

Pair Corralation between GlucoTrack and Nexalin Technology

Given the investment horizon of 90 days GlucoTrack is expected to under-perform the Nexalin Technology. But the stock apears to be less risky and, when comparing its historical volatility, GlucoTrack is 1.4 times less risky than Nexalin Technology. The stock trades about -0.13 of its potential returns per unit of risk. The Nexalin Technology is currently generating about 0.11 of returns per unit of risk over similar time horizon. If you would invest  30.00  in Nexalin Technology on October 25, 2024 and sell it today you would lose (6.00) from holding Nexalin Technology or give up 20.0% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	90.0%
Values	Daily Returns

GlucoTrack  vs.  Nexalin Technology

GlucoTrack

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days GlucoTrack has generated negative risk-adjusted returns adding no value to investors with long positions. Despite conflicting performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in February 2025. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.

Nexalin Technology

Risk-Adjusted Performance

8 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Nexalin Technology are ranked lower than 8 (%) of all global equities and portfolios over the last 90 days. In spite of fairly abnormal forward indicators, Nexalin Technology showed solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with GlucoTrack and Nexalin Technology

The main advantage of trading using opposite GlucoTrack and Nexalin Technology positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlucoTrack position performs unexpectedly, Nexalin Technology can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nexalin Technology will offset losses from the drop in Nexalin Technology's long position.

The idea behind GlucoTrack and Nexalin Technology pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Commodity Channel module to use Commodity Channel Index to analyze current equity momentum.